Design and rationale for MICROFIT (Microvascular Coronary Rehabilitation For Improving Treatment)—a feasibility randomized trial of intensive lifestyle rehabilitation for symptomatic coronary microvascular dysfunction
- DOI
- 10.3389/fcvm.2026.1909948
- Published
- 2026-08-26
- Container
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fcvm.2026.1909948,
title = {Design and rationale for MICROFIT (Microvascular Coronary Rehabilitation For Improving Treatment)—a feasibility randomized trial of intensive lifestyle rehabilitation for symptomatic coronary microvascular dysfunction},
author = {Joanna Abramik and David Murphy and John Graby and Anna Lacey and Theresa Smith and Christopher Lawton and Faith Martin and Fiona Gillison and Matthias G. Friedrich and Amedeo Chiribiri and Mark Mariathas and Kevin Carson and Jonathan Carl Luis Rodrigues and Dylan Thompson and Ali Khavandi},
year = {2026},
journal = {Frontiers in Cardiovascular Medicine},
doi = {10.3389/fcvm.2026.1909948},
url = {https://doi.org/10.3389/fcvm.2026.1909948}
}RIS
TY - JOUR TI - Design and rationale for MICROFIT (Microvascular Coronary Rehabilitation For Improving Treatment)—a feasibility randomized trial of intensive lifestyle rehabilitation for symptomatic coronary microvascular dysfunction AU - Joanna Abramik AU - David Murphy AU - John Graby AU - Anna Lacey AU - Theresa Smith AU - Christopher Lawton AU - Faith Martin AU - Fiona Gillison AU - Matthias G. Friedrich AU - Amedeo Chiribiri AU - Mark Mariathas AU - Kevin Carson AU - Jonathan Carl Luis Rodrigues AU - Dylan Thompson AU - Ali Khavandi PY - 2026 JO - Frontiers in Cardiovascular Medicine DO - 10.3389/fcvm.2026.1909948 UR - https://doi.org/10.3389/fcvm.2026.1909948 ER -
APA
Abramik, J., Murphy, D., Graby, J., Lacey, A., Smith, T., Lawton, C., Martin, F., Gillison, F., Friedrich, M. G., Chiribiri, A., Mariathas, M., Carson, K., Rodrigues, J. C. L., Thompson, D., & Khavandi, A. (2026). Design and rationale for MICROFIT (Microvascular Coronary Rehabilitation For Improving Treatment)—a feasibility randomized trial of intensive lifestyle rehabilitation for symptomatic coronary microvascular dysfunction. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2026.1909948
Source records
- crossref · retrieved 2026-09-27T09:26:31.569Z